ViewpointPercutaneous Coronary Intervention for Chronic Stable Angina: A Reassessment
Under an Elsevier user license
open archive
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ACS
acute coronary syndromes
BMS
bare-metal stent(s)
CABG
coronary artery bypass grafting
CAD
coronary artery disease
DES
drug-eluting stent(s)
FDA
Food and Drug Administration
LV
left ventricular
MI
myocardial infarction
PCI
percutaneous coronary intervention
PTCA
percutaneous transluminal coronary angioplasty
STEMI
ST-segment elevation myocardial infarction
Cited by (0)
Peter Berger, MD, served as Guest Editor for this paper.
- 1
Dr. Gersh serves on the Data Safety and Monitoring Board of Boston Scientific Corporation and on the member advisory boards for Cardiovascular Therapeutics, AstraZeneca, and Bristol-Myers Squibb.
- 2
Dr. Whitlow has participated in research studies with Abbot, Boston Scientific, and Cordis and is on the board of directors for Medlogics, Inc.; is a scientific advisor for Icon, Inc.; and is a stockholder (<$50,000) with Medtronic, Inc.
- 3
Dr. King serves on the medical advisory board for Medtronic, Inc. and has received royalties from Cordis.
Copyright © 2008 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.